QUANTITATIVE NEUROLOGIC AND NEUROBEHAVIORAL TESTING OF PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:29
|
作者
FRANZBLAU, A
LETZ, R
HERSHMAN, D
MASON, P
WALLACE, JI
BEKESI, JG
机构
[1] CUNY MT SINAI SCH MED,DEPT COMMUNITY MED,NEW YORK,NY 10029
[2] CUNY MT SINAI SCH MED,DEPT NUCL ENERGY,NEW YORK,NY 10029
关键词
D O I
10.1001/archneur.1991.00530150031013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Assessment of neurobehavioral and peripheral neurologic performance among homosexual men was made on two occasions, using a computer-administered neurobehavioral instrument and quantitative vibration threshold testing, respectively. Persons studied included high-risk human immunodeficiency virus (HIV)-negative men (n = 13), asymptomatic HIV-positive men (n = 30), and patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS (n = 17). In addition, subjects were characterized immunologically at the time of neurologic and neuropsychologic assessment via determination of circulating lymphocyte counts (total lymphocytes, helper T cells, suppressor T cells, total T cells, activated T cells) and markers of HIV type 1 (HIV-1) infection. At the first cycle of testing, the results of asymptomatic HIV-positive men were indistinguishable from those of HIV-negative men, while persons with AIDS-related complex or AIDS tended to have lower mean performance. These differences did not achieve statistical significance on any single test, but the group with AIDS-related complex or AIDS had the worst mean performance on 12 of 13 individual performance tests. Thirty-seven men underwent repeated testing after a mean interval of approximately 4.5 months. There was little change in mean neurobehavioral performance and vibratory thresholds among all three groups. Measures of neurobehavioral performance and vibrotactile thresholds were not correlated with measures of immunological status. These results are consistent with the concept that asymptomatic infection with HIV-1 does not imply the presence of measurable or significant neurologic or neurobehavioral impairment.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 50 条
  • [21] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY ALCOHOLS
    VANBUEREN, J
    LARKIN, DP
    SIMPSON, RA
    JOURNAL OF HOSPITAL INFECTION, 1994, 28 (02) : 137 - 148
  • [22] HEADACHE AND THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    HOLLOWAY, RG
    KIEBURTZ, KD
    HEADACHE, 1995, 35 (05): : 245 - 255
  • [24] STRUCTURE AND FUNCTION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PAVLAKIS, GN
    SEMINARS IN LIVER DISEASE, 1992, 12 (02) : 103 - 107
  • [25] RENAL COMPLICATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BOURGOIGNIE, JJ
    KIDNEY INTERNATIONAL, 1990, 37 (06) : 1571 - 1584
  • [26] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND CYTOMEGALOVIRUS IN SALIVA
    LUCHT, E
    ALBERT, J
    LINDE, A
    XU, WM
    BRYTTING, M
    LUNDEBERG, J
    UHLEN, M
    BRATT, G
    SANDSTROM, E
    HEIMDAHL, A
    NORD, CE
    WAHREN, B
    JOURNAL OF MEDICAL VIROLOGY, 1993, 39 (02) : 156 - 162
  • [27] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TROPISM FOR HUMAN MACROPHAGES
    COLLMAN, R
    PATHOBIOLOGY, 1992, 60 (04) : 213 - 218
  • [28] ALLYL COMPOUNDS SELECTIVELY KILLED HUMAN-IMMUNODEFICIENCY-VIRUS (TYPE-1)-INFECTED CELLS
    SHOJI, S
    FURUISHI, K
    YANASE, R
    MIYAZAKA, T
    KINO, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (02) : 610 - 621
  • [29] CLINICAL-SIGNIFICANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPES IN INFECTED CHILDREN
    SPENCER, LT
    OGINO, MT
    DANKNER, WM
    SPECTOR, SA
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (03): : 491 - 495
  • [30] KERATOCONJUNCTIVITIS SICCA IN MALE-PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LUCCA, JA
    FARRIS, RL
    BIELORY, L
    CAPUTO, AR
    OPHTHALMOLOGY, 1990, 97 (08) : 1008 - 1010